This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fate Therapeutics Inc (FATE)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012
Cash and Equivalents 49.10M 54.04M 9.09M
Receivables 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 49.87M 54.65M 9.79M
Property, Plant & Equipment, Gross 3.99M 3.11M 2.91M
Accumulated Depreciation & Depletion 2.79M 2.30M 1.75M
Property, Plant & Equipment, Net 1.20M 810.00K 1.16M
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 132.00K 122.00K 122.00K
Total Non-Current Assets 1.33M 932.00K 1.28M
Liabilities & Shareholder Equity
Total Assets 51.20M 55.58M 11.08M
Accounts Payable 645.00K 682.00K 2.27M
Short Term Debt 1.55M 1.73M 1.94M
Other Current Liabilities 45.00K 147.00K 578.00K
Total Current Liabilities 4.58M 4.60M 4.85M
Long Term Debt 18.08M 0.00 1.73M
Deferred Income Taxes 51.00K 135.00K 132.00K
Other Non-Current Liabilities 149.00K 0.00 57.19M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 18.28M 135.00K 59.05M
Total Liabilities 22.86M 4.74M 63.90M
Preferred Stock Equity 0.00 0.00 56.53M
Common Stock Equity 28.34M 50.85M -109.35M
Common Par 21.00K 20.00K 1.00K
Additional Paid In Capital 140.71M 137.34M 12.79M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -112.39M -86.51M -65.61M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 -56.53M
Total Capitalization 46.42M 50.85M -51.09M
Total Equity 28.34M 50.85M -52.83M
Total Liabilities & Stock Equity 51.20M 55.58M 11.08M
Total Common Shares Outstanding 20.57M 20.43M 19.16M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 20.45M 5.90M 7.46M
Diluted Weighted Shares Outstanding 20.45M 5.90M 7.46M
Number of Employees 50 37 NA
Number of Part-Time Employees 0 0 NA

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

FATE Fate Therapeutics Inc

Chart of FATE

Analysts Ratings for FATE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

FATE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs